About Artus Biotech
Artus Biotech is a company based in San Francisco (United States) founded in 2000 was acquired by Qiagen in May 2005. Artus Biotech offers products and services including QIAcuityDx, QIAwave Kits, Proteinase K, TissueLyser III, and QIAseq xHYB Panels. Artus Biotech operates in a competitive market with competitors including ArcherDX, Inflammatix, Karius, MeMed and Visby Medical, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Artus Biotech
Artus Biotech offers a comprehensive portfolio of products and services, including QIAcuityDx, QIAwave Kits, Proteinase K, TissueLyser III, and QIAseq xHYB Panels.
Automated digital PCR system for precise genetic variation detection.
Eco-friendly kits for efficient DNA and RNA extraction processes.
Enzyme for protein digestion in biological sample preparation.
Instrument for lysing samples to enable DNA and RNA analysis.
Targeted NGS panels for viral and bacterial pathogen detection.
Funding Insights of Artus Biotech
Detailed funding history for Artus Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Artus Biotech
Artus Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and reagents for molecular diagnostic assays are supplied.
|
Locked | Locked | Locked |
Investor details for Artus Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Artus Biotech
Investment portfolio details for Artus Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Artus Biotech
Detailed financials for Artus Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artus Biotech Comparisons
Peer comparison for Artus Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Artus Biotech
Artus Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Inflammatix, Karius, MeMed and Visby Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
Detailed competitors of Artus Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artus Biotech
Complete news archive for Artus Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artus Biotech
Artus Biotech was founded in 2000.
Artus Biotech is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Artus Biotech was established in 2000 in San Francisco, United States, within the biotechnology sector. Operations centered on the creation of PCR-based molecular diagnostics tools, including real-time PCR kits designed for in vitro applications. These products were applied in pathogen detection, genotyping, and pharmacogenomics, supporting clinical and research needs in diagnostics. The company maintained a focus on reliable, targeted assay development for healthcare and scientific use.
Artus Biotech's top competitors include Visby Medical, Inflammatix and MeMed.
Artus Biotech offers QIAcuityDx, QIAwave Kits, Proteinase K, TissueLyser III, and QIAseq xHYB Panels.
Artus Biotech has 1 investor. Key investors include Qiagen.